Skip to Main Content

Paper Details

A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy.
Clin Cancer Res
28
2017
Author NameAffiliation
Andrew J EvansPrincess Margaret Cancer Centre
Antonio Hurtado-CollUniversity of British Columbia
Girish S KulkarniPrincess Margaret Cancer Centre
Antonio FinelliPrincess Margaret Cancer Centre
Alexandre R ZlottaPrincess Margaret Cancer Centre
Martin E GleaveUniversity of British Columbia
Neil E FleshnerPrincess Margaret Cancer Centre
  • 1 - 7

Datasets

Release 1.2